Open AccessCHRONIC VIRAL HEPATITIS C MICRO-ELIMINATION PROGRAM USING TELEMEDICINE. THE MEXICAN EXPERIENCE
Author(s) -
JOSE LUIS PEREZ HERNANDEZ,
Rodolfo Lehmann Mendoza,
Javier Luna Martinez,
José Fernando Torres Roldan,
Pedro Armando Chaidez Rosales,
Hilario Ascencion Martinez Arredondo,
Veronica Rebollar Gonzalez,
Lourdes De la Cruz Silva,
Daniel Santana-Vargas,
María de Fátima Higuera de la Tijera,
César Alejandro Arce Salinas
Publication year - 2020
Publication title -
revista española de enfermedades digestivas/revista española de enfermedades digestivas
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.331
H-Index - 38
eISSN - 2340-4167
pISSN - 1130-0108
DOI - 10.17235/reed.2020.7425/2020
Subject(s) - medicine , telemedicine , hepatitis c , covid-19 , virology , viral hepatitis , health care , disease , infectious disease (medical specialty) , economics , economic growth
hepatitis C virus (HCV) infection is a global health problem. Chronic infection induces the development of fibrosis and cirrhosis together with all the related complications. The use of direct-acting antiviral (DAA) drugs has proven highly effective. Telemedicine is a present-day resource that brings treatment closer to distant areas and may result in cost savings.